Skip to main content
Premium Trial:

Request an Annual Quote

UgenTec Raises $1.4M from Investors, Government Agency

NEW YORK (GenomeWeb) – Belgian software startup UgenTec has received more than €1 million (about $1.06) in venture capital funding from a group of Belgian investors, and an additional €250,000 ($265,000) in research funds from the IWT, a Belgium government agency for Innovation by Science and Technology.

The company has also received a €100,000 ($106,000) loan from LRM, a Belgian investment company.

The list of investors includes Annie Vereecken, former CEO of MedHold (now part of Sonic Healthcare), Cartagenia CEO Herman Verrelst, and a KULeuven investment group Bart De Moor.

Wouter Uten, CEO of UgenTec, said that the company will use the funds to develop FastFinder, its laboratory software for automated PCR-based DNA analysis. FastFinder is currently being used by several diagnostic laboratories in Benelux, Germany, and France, and an additional 50 European laboratories will implement the solution this year, according to the company.

UgenTec also plans to develop new functionality for its software and will recruit extra developers as well as biotechnicians for various roles. It has already added three new employees to its existing eight-person staff, and intends to hire additional talent to bring its total workforce to 15 people.

The funds will also support UgenTec's international expansion plans. "We want to expand pan-European in the short term, and also prepare for commercializing FastFinder in the US market in the next 18 months" pending approval from the US Food and Drug Administration, Uten said.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.